Vigil Neuroscience, Inc. (CIK: 0001827087) EDGAR, Information, Filings... CompaniesBIO.Com

Vigil Neuroscience, Inc.

Mailing address
1 BROADWAY, 7TH FLOOR, SUITE 07-300, CAMBRIDGE, Delaware, 02142
Phone
857-254-4445
State location
Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Filings
N/A

Vigil Neuroscience, Inc. (CIK: 0001827087) is an American company incorporated in the state of Massachusetts. Head office is located at 1 BROADWAY, 7TH FLOOR, SUITE 07-300, CAMBRIDGE, Massachusetts, 02142. Work in the industry 2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES). Vigil Neuroscience, Inc. is a public company and trade via Over-The-Counter (OTC).

Owner	Filings	Transaction Date	Type of Owner
Silber Christopher	0001988360	Aug-07-2023	officer: Chief Medical Officer
Budd Haeberlein Samantha L.	0001976326	May-08-2023	director
Gray David L. F.	0001966743	Feb-27-2023	officer: Chief Science Officer
Bruhn Suzanne Louise	0001517790	Jul-27-2022	director
Verni Christopher	0001920537	Apr-19-2022	officer: General Counsel
Thistle Mary	0001317917	Apr-18-2022	director
AMGEN INC	0000318154	Jan-06-2022	10 percent owner
Magovcevic-Liebisch Ivana	0001279281	Jan-06-2022	director, officer: President and CEO
Blanchard Cheryl R	0001326530	Jan-06-2022	director
Booth Bruce	0001451612	Jan-06-2022	director
Cormorant Asset Management, LP	0001583977	Jan-06-2022	10 percent owner
Thorp Clay	0001592380	Jan-06-2022	director
Chen Bihua	0001599214	Jan-06-2022	10 percent owner
Cormorant Global Healthcare Master Fund, LP	0001618442	Jan-06-2022	10 percent owner
Alexandria Venture Investments, LLC	0001722024	Jan-06-2022	10 percent owner
Ziolkowski Jennifer Lynn	0001727410	Jan-06-2022	officer: Chief Financial Officer
Atlas Venture Opportunity Fund I, L.P.	0001759241	Jan-06-2022	10 percent owner
Atlas Venture Associates Opportunity I, L.P.	0001780065	Jan-06-2022	10 percent owner
Atlas Venture Associates Opportunity I, LLC	0001780066	Jan-06-2022	10 percent owner
Atlas Venture Fund XII, L.P.	0001812049	Jan-06-2022	10 percent owner
Vitorovic Stefan	0001826967	Jan-06-2022	director
Papapetropoulos Spyridon	0001832694	Jan-06-2022	officer: Chief Medical Officer
Atlas Venture Associates XII, LLC	0001845871	Jan-06-2022	10 percent owner
Atlas Venture Associates XII, L.P.	0001845875	Jan-06-2022	10 percent owner
Vida Ventures GP III, L.L.C.	0001855502	Jan-06-2022	10 percent owner
Vida Ventures III-A, L.P.	0001855503	Jan-06-2022	10 percent owner
Vida Ventures III, L.P.	0001855504	Jan-06-2022	10 percent owner
Northpond Ventures GP, LLC	0001867470	Jan-06-2022	10 percent owner
Northpond Ventures, LP	0001867472	Jan-06-2022	10 percent owner
Rubin Michael P.	0001867627	Jan-06-2022	10 percent owner
Northpond Ventures GP II, LLC	0001869114	Jan-06-2022	10 percent owner
Northpond Ventures II, LP	0001869128	Jan-06-2022	10 percent owner
Cormorant Private Healthcare Fund IV LP	0001871297	Jan-06-2022	10 percent owner
Gandhi Shaan-Chirag C	0001873448	Jan-06-2022	director
Koenig Gerhard	0001886325	Jan-06-2022	director
Thackaberry Evan	0001889253	Jan-06-2022	officer: SVP, Head of Early Development

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Vigil Neuroscience, Inc.

Filings	Format	Description	Filed/Effective	File/Film Number
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950170-24-095755 (34 Act) Size: 6729 KB	Aug-13-2024	001-41200 241198785
8-K	Document	Current report filing Acc-no: 0001193125-24-199396 (34 Act) Size: 212 KB	Aug-13-2024	001-41200 241198757
SC 13G	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001193125-24-198965 (34 Act) Size: 143 KB	Aug-12-2024	005-93233 241197783
8-K	Document	Current report filing Acc-no: 0001193125-24-183318 (34 Act) Size: 191 KB	Jul-24-2024	001-41200 241136102
8-K	Document	Current report filing Acc-no: 0001193125-24-180727 (34 Act) Size: 175 KB	Jul-18-2024	001-41200 241123694
8-K	Document	Current report filing Acc-no: 0001193125-24-170520 (34 Act) Size: 583 KB	Jun-27-2024	001-41200 241079190
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-070843 ( Act) Size: 5 KB	Jun-07-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-070842 ( Act) Size: 5 KB	Jun-07-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-070841 ( Act) Size: 5 KB	Jun-07-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-070840 ( Act) Size: 5 KB	Jun-07-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-070839 ( Act) Size: 5 KB	Jun-07-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-070838 ( Act) Size: 5 KB	Jun-07-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-070837 ( Act) Size: 5 KB	Jun-07-2024
8-K	Document	Current report filing Acc-no: 0001193125-24-156044 (34 Act) Size: 309 KB	Jun-06-2024	001-41200 241025035
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-054708 ( Act) Size: 22 KB	May-07-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-054700 ( Act) Size: 12 KB	May-07-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-054707 ( Act) Size: 13 KB	May-07-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-054699 ( Act) Size: 17 KB	May-07-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-054705 ( Act) Size: 8 KB	May-07-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-054698 ( Act) Size: 17 KB	May-07-2024

Recent 20 filings. View all Vigil Neuroscience, Inc. filings

Overall rating 5.0

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Vigil Neuroscience, Inc. overview
Vigil Neuroscience, Inc. job
Vigil Neuroscience, Inc. stock
Vigil Neuroscience, Inc. ownership
Vigil Neuroscience, Inc. CEO
Vigil Neuroscience, Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.